Neus Villamor

Neus Villamor publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Neus Villamor sits on this spectrum.

Neus Villamor D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Neus Villamor sits on this spectrum.

Best Publications

• Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

  Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde

  1857
  Citations

• ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

  Marta Crespo;Francesc Bosch;Neus Villamor;Beatriz Bellosillo

  1718
  Citations

• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

  Víctor Quesada;Laura Conde;Neus Villamor;Gonzalo R Ordóñez

  1225
  Citations

• Non-coding recurrent mutations in chronic lymphocytic leukaemia

  Xose S. Puente;Silvia Beà;Rafael Valdés-Mas;Neus Villamor

  1012
  Citations

• The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

  Patricia Pérez-Galán;Gaël Roué;Neus Villamor;Emili Montserrat

  579
  Citations

• International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

  A C Rawstron;N Villamor;M Ritgen;S Böttcher

  493
  Citations

• PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma

  F Bosch;P Jares;E Campo;A Lopez-Guillermo

  430
  Citations

• Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin

  Armando López-Guillermo;Luis Colomo;Mónica Jiménez;Francesc Bosch

  381
  Citations

• Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia

  Ferran Nadeu;Julio Delgado;Cristina Royo;Tycho Baumann

  379
  Citations

• Gene expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

  Gonzalo Gutiérrez-García;Teresa Cardesa-Salzmann;Fina Climent;Eva González-Barca

  376
  Citations

• Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.

  Eduardo Arellano-Rodrigo;Alberto Alvarez-Larrán;Juan Carlos Reverter;Neus Villamor

  365
  Citations

• Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

  P Baliakas;A Hadzidimitriou;L-A Sutton;D Rossi

  360
  Citations

• High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

  Joaquim Carreras;Armando Lopez-Guillermo;Giovanna Roncador;Neus Villamor

  342
  Citations

• Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species.

  Beatriz Bellosillo;Neus Villamor;Armando López-Guillermo;Silvia Marcé

  311
  Citations

• Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells.

  Beatriz Bellosillo;Maria Piqué;Montserrat Barragán;Esther Castaño

  286
  Citations

• Harms and benefits of lymphocyte subpopulations in patients with acute stroke.

  X. Urra;Á. Cervera;N. Villamor;A.M. Planas

  268
  Citations

• NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

  N Villamor;L Conde;A Martínez-Trillos;M Cazorla

  245
  Citations

• Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia.

  Francesc Bosch;Anna Ferrer;Armando López‐Guillermo;Eva Giné

  243
  Citations

• Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL

  A C Rawstron;A C Rawstron;S Böttcher;R Letestu;N Villamor

  242
  Citations

• Monocyte subtypes predict clinical course and prognosis in human stroke.

  Xabier Urra;Neus Villamor;Sergio Amaro;Manuel Gómez-Choco

  236
  Citations